Abstract
Background Exercise may prevent the progression of liver disease and protect against liver cancer. This review with meta-analysis synthesised the evidence from both human and animal studies to better understand whether exercise has the capacity to (i) promote regression of early fibrosis; (ii) decrease and/or delay progression to cirrhosis; and (iii) progression to carcinoma.
Methods A systematic search was performed to identify studies comprising of humans and animals with liver disease that compared exercise to an inactive or less active control. Outcomes included liver disease regression and progression, and markers of liver function and damage.
Results We found 18 human and 29 animal studies. A single study provided direct evidence that exercise can reverse NAFLD and decrease progression to cirrhosis. Meta-analysis of human studies identified decreases in liver enzymes; ALT (SMD = -0.28, 95%CI = -0.53, -0.03), AST (SMD = -0.12, 95%CI = -0.32, 0.07), GGT (SMD = -0.23, 95%CI = -0.36, -0.10), as well as a small increase in ALP (SMD = 0.23, 95%CI = -0.13, 0.59), and liver triglycerides (SMD = -0.24, 95%CI = -0.66, 0.18). Meta-analysis of animal studies identified decreases in liver enzymes; ALT (SMD = -2.85, 95%CI = -4.55, -1.14), AST (SMD = -2.85, 95%CI = -4.55, -1.14), and liver triglycerides (SMD = -1.36, 95%CI = -2.08, -0.65), liver weight (SMD = -1.94, 95%CI = -2.78, - 1.10), and the NAFLD activity score (SMD = -1.36, 95%CI = -2.08, -0.65).
Conclusion Only one study provided direct evidence that exercise has the capacity to regress early fibrosis, as well as delay the progression to cirrhosis. Several studies, however, indicate that exercise intervention reduce markers of liver function and damage.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
